Silo Pharma (SILO) Total Non-Current Liabilities (2020 - 2025)
Historic Total Non-Current Liabilities for Silo Pharma (SILO) over the last 6 years, with Q3 2025 value amounting to $667502.0.
- Silo Pharma's Total Non-Current Liabilities fell 974.87% to $667502.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $667502.0, marking a year-over-year decrease of 974.87%. This contributed to the annual value of $721578.0 for FY2024, which is 908.45% down from last year.
- According to the latest figures from Q3 2025, Silo Pharma's Total Non-Current Liabilities is $667502.0, which was down 974.87% from $685527.0 recorded in Q2 2025.
- In the past 5 years, Silo Pharma's Total Non-Current Liabilities ranged from a high of $973935.0 in Q2 2021 and a low of $667502.0 during Q3 2025
- Over the past 5 years, Silo Pharma's median Total Non-Current Liabilities value was $829731.0 (recorded in 2023), while the average stood at $827331.8.
- Its Total Non-Current Liabilities has fluctuated over the past 5 years, first soared by 2198864.81% in 2021, then plummeted by 974.87% in 2025.
- Quarter analysis of 5 years shows Silo Pharma's Total Non-Current Liabilities stood at $937884.0 in 2021, then fell by 7.69% to $865782.0 in 2022, then decreased by 8.33% to $793680.0 in 2023, then fell by 9.08% to $721578.0 in 2024, then fell by 7.49% to $667502.0 in 2025.
- Its Total Non-Current Liabilities was $667502.0 in Q3 2025, compared to $685527.0 in Q2 2025 and $703553.0 in Q1 2025.